TRENDS IN CELL AND GENE THERAPY UPTAKE AND UTILIZATION IN THE UNITED STATES: A REAL-WORLD ANALYSIS OF THE KOMODO HEALTHCARE MAP™ CLAIMS DATA FROM 2015-2021

被引：0
作者：
Oak, B. [1 ]
Silber, A. [2 ]
Goldman, E. [1 ]
Liu, R. [1 ]
Verma, D. [3 ]
Francis, K. [1 ]
Hadker, N. [1 ]
机构：
[1] Trinity Life Sci, Waltham, MA USA
[2] Trinity Partners LLC, Waltham, MA USA
[3] Trinity Life Sci, Gurgaon, MA, India
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD93
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [1] Real-World Talquetamab Utilization Patterns and Dose Schedules in the United States: An Analysis Using Claims Data
    Banerjee, Rahul
    Wang, Ruibin
    Liu, Yi-Hsuan
    He, Jinghua
    Le, Hoa H.
    Patel, Saurabh N.
    Zhang, Xinke
    BLOOD, 2024, 144 : 2392 - 2393
  • [2] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Philip J. Mease
    Pamela Young
    David Gruben
    Lara Fallon
    Rebecca Germino
    Arthur Kavanaugh
    Advances in Therapy, 2022, 39 : 2932 - 2945
  • [3] EARLY REAL-WORLD EXPERIENCE OF TOFACITINIB FOR PSORIATIC ARTHRITIS: DATA FROM A UNITED STATES HEALTHCARE CLAIMS DATABASE
    Mease, P. J.
    Young, P.
    Gruben, D. C.
    Fallon, L.
    Germino, R.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1286 - 1287
  • [4] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip J.
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ADVANCES IN THERAPY, 2022, 39 (06) : 2932 - 2945
  • [6] Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021
    Adjei, Naomi N.
    Haas, Allen
    Zhao, Hui
    Primm, Kristin M.
    Giordano, Sharon H.
    Sun, Charlotte C.
    Meyer, Larissa A.
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 255 - 261
  • [7] UTILIZATION OF NONSTEROIDAL MRA FINERENONE: EVALUATION OF REAL-WORLD DATA IN THE UNITED STATES, 2021-2023
    Singh, Ajay
    Singh, Rakesh
    Du, Yuxian
    Kong, Sheldon
    McDermott, Kimberly
    Lavelle, Kevin
    Farag, Youssef
    Farej, Ryan
    Williamson, Todd
    Kallenbach, Lee
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S103 - S103
  • [8] HEALTHCARE RESOURCE UTILIZATION AND COST BURDEN OF FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: A REAL-WORLD CLAIMS DATABASE ANALYSIS IN THE UNITED STATES
    Hebert, A. A.
    Paydar, C.
    Das, A. K.
    Boggarapu, S.
    Beresford, E.
    VALUE IN HEALTH, 2023, 26 (06) : S134 - S134
  • [9] Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
    Packnett, Elizabeth R.
    Zimmerman, Nicole M.
    Novy, Patricia
    Morgan, Laura C.
    Chime, Nnenna
    Ghaswalla, Parinaz
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [10] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
    Tepper, S. J.
    Schwedt, T. J.
    Vo, P.
    Joshi, P.
    Glassberg, M.
    Abdrabboh, A.
    Ferraris, M.
    Tiwari, S.
    Thompson, J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 26 - 26
12345